a real negative bunch of share holders, page-5

Hi miso,

I have spilled the beans over GSK and the Relenza story at various posts going back a few years now.

As I have said in my previous posts, the Relenza royalies have nothing to do with the BTA management.

Relenza royalites will come in regardless how management performs. The other medicines in the pipeline the same, they are now in the hands of multi nationals who will develop them furher and pay BTA royalties.

I have made some good returns from BTA in the past, I knew when to get out at the time.
And now I think its a good time to put some money back in.

But time will tell who is right.

good luck

jojo